Tactogen
Palo Alto · Founded 2020
About Tactogen
Tactogen is a biopharma startup that develops empathogen medicines. The startup company offers drug discovery methods, novel molecules, and pharmaceutical preparations that focus on one goal: enabling safer take-home prescription empathogens. It is headquartered in Palo Alto, California in 2020 by Ph.D. neuroscientist Matthew Baggott and deeptech serial entrepreneur Luke Pustejovsky.
Company Facts
- Founded: 2020
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Jan 2022)
- Website: tactogen.com
Social Profiles
Canonical: https://fsome.com/organization/tactogen-8277612 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.